| pubmed-article:17891058 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17891058 | lifeskim:mentions | umls-concept:C0154830 | lld:lifeskim |
| pubmed-article:17891058 | lifeskim:mentions | umls-concept:C0796392 | lld:lifeskim |
| pubmed-article:17891058 | lifeskim:mentions | umls-concept:C1522577 | lld:lifeskim |
| pubmed-article:17891058 | lifeskim:mentions | umls-concept:C1517572 | lld:lifeskim |
| pubmed-article:17891058 | lifeskim:mentions | umls-concept:C1656863 | lld:lifeskim |
| pubmed-article:17891058 | lifeskim:mentions | umls-concept:C1135130 | lld:lifeskim |
| pubmed-article:17891058 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:17891058 | pubmed:dateCreated | 2009-1-16 | lld:pubmed |
| pubmed-article:17891058 | pubmed:abstractText | To study the effects of intravitreal bevacizumab (Avastin) on retinal neovascularization (RN) in patients with proliferative diabetic retinopathy (PDR). | lld:pubmed |
| pubmed-article:17891058 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17891058 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17891058 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17891058 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17891058 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17891058 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17891058 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17891058 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17891058 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:17891058 | pubmed:issn | 1476-5454 | lld:pubmed |
| pubmed-article:17891058 | pubmed:author | pubmed-author:WuLL | lld:pubmed |
| pubmed-article:17891058 | pubmed:author | pubmed-author:MahyDD | lld:pubmed |
| pubmed-article:17891058 | pubmed:author | pubmed-author:EvansTT | lld:pubmed |
| pubmed-article:17891058 | pubmed:author | pubmed-author:FernandezC... | lld:pubmed |
| pubmed-article:17891058 | pubmed:author | pubmed-author:ArevaloJ FJF | lld:pubmed |
| pubmed-article:17891058 | pubmed:author | pubmed-author:SanchezJ GJG | lld:pubmed |
| pubmed-article:17891058 | pubmed:author | pubmed-author:SaraviaM JMJ | lld:pubmed |
| pubmed-article:17891058 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:17891058 | pubmed:volume | 23 | lld:pubmed |
| pubmed-article:17891058 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17891058 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17891058 | pubmed:pagination | 117-23 | lld:pubmed |
| pubmed-article:17891058 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:17891058 | pubmed:meshHeading | pubmed-meshheading:17891058... | lld:pubmed |
| pubmed-article:17891058 | pubmed:meshHeading | pubmed-meshheading:17891058... | lld:pubmed |
| pubmed-article:17891058 | pubmed:meshHeading | pubmed-meshheading:17891058... | lld:pubmed |
| pubmed-article:17891058 | pubmed:meshHeading | pubmed-meshheading:17891058... | lld:pubmed |
| pubmed-article:17891058 | pubmed:meshHeading | pubmed-meshheading:17891058... | lld:pubmed |
| pubmed-article:17891058 | pubmed:meshHeading | pubmed-meshheading:17891058... | lld:pubmed |
| pubmed-article:17891058 | pubmed:meshHeading | pubmed-meshheading:17891058... | lld:pubmed |
| pubmed-article:17891058 | pubmed:meshHeading | pubmed-meshheading:17891058... | lld:pubmed |
| pubmed-article:17891058 | pubmed:meshHeading | pubmed-meshheading:17891058... | lld:pubmed |
| pubmed-article:17891058 | pubmed:meshHeading | pubmed-meshheading:17891058... | lld:pubmed |
| pubmed-article:17891058 | pubmed:meshHeading | pubmed-meshheading:17891058... | lld:pubmed |
| pubmed-article:17891058 | pubmed:meshHeading | pubmed-meshheading:17891058... | lld:pubmed |
| pubmed-article:17891058 | pubmed:meshHeading | pubmed-meshheading:17891058... | lld:pubmed |
| pubmed-article:17891058 | pubmed:meshHeading | pubmed-meshheading:17891058... | lld:pubmed |
| pubmed-article:17891058 | pubmed:meshHeading | pubmed-meshheading:17891058... | lld:pubmed |
| pubmed-article:17891058 | pubmed:meshHeading | pubmed-meshheading:17891058... | lld:pubmed |
| pubmed-article:17891058 | pubmed:meshHeading | pubmed-meshheading:17891058... | lld:pubmed |
| pubmed-article:17891058 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:17891058 | pubmed:articleTitle | Intravitreal bevacizumab (Avastin) for proliferative diabetic retinopathy: 6-months follow-up. | lld:pubmed |
| pubmed-article:17891058 | pubmed:affiliation | Retina and Vitreous Service, Clinica Oftalmológica Centro Caracas, Caracas, Venezuela. arevalojf2020@gmail.com | lld:pubmed |
| pubmed-article:17891058 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17891058 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:17891058 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17891058 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17891058 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17891058 | lld:pubmed |
